WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹321 Cr | ₹249 Cr | ₹172 Cr | ₹121 Cr | ₹94 Cr |
What is the latest Total Current Liabilities ratio of WINDLAS BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹321 Cr |
| Mar2025 | ₹249 Cr |
| Mar2024 | ₹172 Cr |
| Mar2023 | ₹121 Cr |
| Mar2022 | ₹94 Cr |
How is Total Current Liabilities of WINDLAS BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹321 Cr | 28.66 | |
| Mar2025 | ₹249 Cr | 45.24 | |
| Mar2024 | ₹172 Cr | 41.66 | |
| Mar2023 | ₹121 Cr | 29.00 | |
| Mar2022 | ₹94 Cr | - | |
Compare Total Current Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,697.5 Cr | -1.2% | 4.6% | -3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -1.2% |
4.6% |
-3.5% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses